• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸盐对破骨细胞分化和功能的调节:破骨细胞在低磷血症性骨骼异常中的潜在作用。

Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions.

作者信息

Hayashibara Tetsuyuki, Hiraga Toru, Sugita Atsushi, Wang Liyang, Hata Kenji, Ooshima Takashi, Yoneda Toshiyuki

机构信息

Department of Biochemistry, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.

出版信息

J Bone Miner Res. 2007 Nov;22(11):1743-51. doi: 10.1359/jbmr.070709.

DOI:10.1359/jbmr.070709
PMID:17638577
Abstract

UNLABELLED

Mice fed with a low Pi diet exhibited decreased osteoclast number. Hyp mice also showed decreased osteoclasts, and high Pi reversed it. Low Pi reduced osteoclast formation and bone resorption in vitro. Hypophosphatemia may suppress osteoclast differentiation/function, leading to skeletal abnormalities.

INTRODUCTION

Skeletal abnormalities seen in hypophosphatemic disorders indicate a critical role of phosphate (Pi) in skeletogenesis. However, the role of osteoclasts in the pathogenesis of the disturbed skeletogenesis is unclear.

MATERIALS AND METHODS

Mice fed with a low-Pi diet and Hyp mice that are characterized by hypophosphatemia and impaired osteogenesis were studied. Effects of Pi on osteoclast formation and bone resorption were also examined in vitro.

RESULTS

Histomorphometric examination showed that mice on a low-Pi diet exhibited decreased osteoclast number. Furthermore, osteoclast number in Hyp mice was also decreased compared with wildtype (WT) mice. Of note, feeding of Hyp mice with high-Pi diet significantly reversed hypophosphatemia, improved disturbed osteogenesis, and increased osteoclast number. Osteoclast-like cell (OLC) formation and bone resorption in Hyp bone marrow cells was not different from WT bone marrow cells. On the other hand, OLC formation and bone resorption were decreased in conjunction with reduced mRNA expression of RANKL in WT bone marrow cells cultured in the medium containing low Pi (0.5 mM). Recombinant human matrix extracellular phosphoglycoprotein (MEPE), a candidate for phosphatonin, also decreased osteoclast formation, whereas fibroblast growth factor 23 (FGF23), another phosphatonin candidate, showed no effects.

CONCLUSIONS

Our results suggest that Pi controls the differentiation and function of osteoclasts. These actions of Pi on osteoclasts may be associated with the pathogenesis of the skeletal abnormalities in hypophosphatemic disorders.

摘要

未标记

喂食低磷饮食的小鼠破骨细胞数量减少。Hyp小鼠的破骨细胞也减少,高磷可使其逆转。低磷在体外可减少破骨细胞形成和骨吸收。低磷血症可能抑制破骨细胞分化/功能,导致骨骼异常。

引言

低磷血症性疾病中出现的骨骼异常表明磷酸盐(Pi)在骨骼发育中起关键作用。然而,破骨细胞在骨骼发育紊乱发病机制中的作用尚不清楚。

材料和方法

研究了喂食低磷饮食的小鼠以及以低磷血症和成骨受损为特征的Hyp小鼠。还在体外检测了磷对破骨细胞形成和骨吸收的影响。

结果

组织形态计量学检查显示,喂食低磷饮食的小鼠破骨细胞数量减少。此外,与野生型(WT)小鼠相比,Hyp小鼠的破骨细胞数量也减少。值得注意的是,给Hyp小鼠喂食高磷饮食可显著逆转低磷血症,改善成骨紊乱,并增加破骨细胞数量。Hyp骨髓细胞中破骨细胞样细胞(OLC)的形成和骨吸收与WT骨髓细胞无差异。另一方面,在含低磷(0.5 mM)培养基中培养的WT骨髓细胞中,OLC形成和骨吸收减少,同时RANKL的mRNA表达降低。磷调节素候选物重组人基质细胞外磷酸糖蛋白(MEPE)也可减少破骨细胞形成,而另一种磷调节素候选物成纤维细胞生长因子23(FGF23)则无作用。

结论

我们的结果表明磷控制破骨细胞的分化和功能。磷对破骨细胞的这些作用可能与低磷血症性疾病中骨骼异常的发病机制有关。

相似文献

1
Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions.磷酸盐对破骨细胞分化和功能的调节:破骨细胞在低磷血症性骨骼异常中的潜在作用。
J Bone Miner Res. 2007 Nov;22(11):1743-51. doi: 10.1359/jbmr.070709.
2
Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.高磷酸盐浓度对破骨细胞分化以及骨吸收活性的影响。
J Cell Physiol. 2003 Jul;196(1):180-9. doi: 10.1002/jcp.10270.
3
Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.来自基质细胞外磷酸糖蛋白的磷酸化富含酸性丝氨酸-天冬氨酸的MEPE相关基序肽抑制与X染色体上内肽酶具有同源性的磷酸盐调节基因的酶活性。
J Endocrinol. 2007 Jan;192(1):261-7. doi: 10.1677/joe.1.07059.
4
Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.MEPE、DMP1的降解以及SIBLING ASARM肽(微小抑制素)的释放:ASARM肽直接导致低磷性骨软化症中的矿化缺陷。
Endocrinology. 2008 Apr;149(4):1757-72. doi: 10.1210/en.2007-1205. Epub 2007 Dec 27.
5
Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts.骨桥蛋白缺乏通过对破骨细胞的特异性调节抑制高磷负荷诱导的骨质流失。
Endocrinology. 2006 Jun;147(6):3040-9. doi: 10.1210/en.2005-0671. Epub 2006 Mar 2.
6
Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia.基质细胞外磷酸糖蛋白在X连锁低磷血症发病机制中的作用。
J Am Soc Nephrol. 2005 Jun;16(6):1645-53. doi: 10.1681/ASN.2004121060. Epub 2005 Apr 20.
7
Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
J Bone Miner Res. 1991 May;6(5):473-8. doi: 10.1002/jbmr.5650060508.
8
BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.骨唾液蛋白(BSP)和核因子κB受体活化因子配体(RANKL)协同诱导破骨细胞生成和骨吸收。
J Bone Miner Res. 2005 Sep;20(9):1669-79. doi: 10.1359/JBMR.050511. Epub 2005 May 16.
9
Identification of the type II Na(+)-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice.破骨细胞中II型钠-磷共转运体(Npt2)的鉴定及Npt2基因敲除小鼠的骨骼表型
Bone. 2001 Nov;29(5):467-76. doi: 10.1016/s8756-3282(01)00601-9.
10
Serotonin regulates osteoclast differentiation through its transporter.血清素通过其转运体调节破骨细胞分化。
J Bone Miner Res. 2004 Sep;19(9):1420-31. doi: 10.1359/JBMR.040606. Epub 2004 Jun 21.

引用本文的文献

1
Phosphate in Physiological and Pathological Mineralization: Important yet Often Unheeded.磷酸盐在生理和病理矿化中的作用:重要却常被忽视。
MedComm (2020). 2025 Jul 13;6(7):e70298. doi: 10.1002/mco2.70298. eCollection 2025 Jul.
2
FAM20C: A key protein kinase in multiple diseases.FAM20C:多种疾病中的关键蛋白激酶。
Genes Dis. 2023 Nov 23;12(2):101179. doi: 10.1016/j.gendis.2023.101179. eCollection 2025 Mar.
3
Phytochemical Compounds Involved in the Bone Regeneration Process and Their Innovative Administration: A Systematic Review.
参与骨再生过程的植物化学化合物及其创新给药方式:一项系统综述。
Plants (Basel). 2023 May 22;12(10):2055. doi: 10.3390/plants12102055.
4
Meclozine ameliorates bone mineralization and growth plate structure in a mouse model of X‑linked hypophosphatemia.美克洛嗪改善X连锁低磷血症小鼠模型的骨矿化和生长板结构。
Exp Ther Med. 2022 Nov 30;25(1):39. doi: 10.3892/etm.2022.11738. eCollection 2023 Jan.
5
FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes.FAM20C 概述:经典和新型靶标、致病性变异和 Raine 综合征表型。
Int J Mol Sci. 2021 Jul 27;22(15):8039. doi: 10.3390/ijms22158039.
6
Effect of high phosphate diet on the formation of dentin in Fam20c-deficient mice.高磷饮食对 Fam20c 缺陷型小鼠牙本质形成的影响。
Eur J Oral Sci. 2021 Jun;129(3):e12795. doi: 10.1111/eos.12795. Epub 2021 Apr 27.
7
Ablation of Pyrophosphate Regulators Promotes Periodontal Regeneration.焦磷酸盐调节剂的消融促进牙周组织再生。
J Dent Res. 2021 Jun;100(6):639-647. doi: 10.1177/0022034520981854. Epub 2020 Dec 24.
8
Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging.饮食磷对骨骼代谢和健康老龄化的重要性。
Nutrients. 2020 Sep 30;12(10):3001. doi: 10.3390/nu12103001.
9
Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.骨细胞相关细胞因子调节破骨细胞的形成和骨吸收。
Int J Mol Sci. 2020 Jul 21;21(14):5169. doi: 10.3390/ijms21145169.
10
High-Phosphate Diet Improved the Skeletal Development of Fam20c-Deficient Mice.高磷饮食可改善 Fam20c 缺陷型小鼠的骨骼发育。
Cells Tissues Organs. 2019;208(1-2):25-36. doi: 10.1159/000506005. Epub 2020 Feb 26.